Valerio Therapeutics to Acquire Etherna Immunotherapies, Prices €40.25 Million PIPE
Valerio Therapeutics signed definitive agreements to acquire 100% of Etherna Immunotherapies at a €30 million enterprise value and priced a €40.25 million private investment in public equity. The transaction would combine targeted-moiety engineering, nucleic-acid…
